Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Colimesta 4.5 MIU Injection

Prescription Icon
Prescription Required

Marketer

Alvista Biosciences Pvt Ltd

Salt Composition

Colistimethate Sodium (4500000IU)

Overview Colimesta 4.5 MIU Injection

Colistimethate sodium 4.5 MIU injection combats bacterial infections. This potent antibiotic is indicated for treating serious systemic bacterial infections, primarily in hospitalized patients with critical illness. Administration must be overseen by a qualified healthcare provider; self-administration is strictly prohibited. Dosage and treatment length are determined by your physician, tailored to your infection's severity and nature. Consistent adherence to the prescribed injection schedule is crucial for optimal therapeutic outcomes. Potential adverse reactions include nausea, vomiting, speech impairment, lightheadedness, spinning sensations, elevated temperature, skin rashes, and tingling sensations. These effects are generally transient, resolving as the body adapts. However, persistent or bothersome side effects warrant immediate medical attention. Prior to commencing treatment, inform your doctor of any antibiotic allergies, pre-existing liver or kidney conditions. Expectant or nursing mothers must consult their physician before use. Regular blood tests to monitor kidney function and drug levels may be ordered by your doctor.

Primary Ingredients of Colimesta 4.5 MIU Injection

No text provided to rephrase.

Uses of Colimesta 4.5 MIU Injection

Life-threatening bacterial infections

Major Benefits of Colimesta 4.5 MIU Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Colimesta 4.5 MIU Injection:

  • Slurred speech
  • Upset stomach
  • Dizziness
  • Gastrointestinal disturbance
  • Paresthesia (tingling or pricking sensation)
  • Vertigo
  • Rash
  • Fever
  • Generalized itching
  • Red spots or bumps
  • Increased blood urea nitrogen
  • Increased creatinine level in blood
  • Decreased creatinine clearance
  • Respiratory distress
  • Apnea (absence of breathing)
  • Renal toxicity
  • Decreased urinary volume

How to use Colimesta 4.5 MIU Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Colimesta 4.5 MIU Injection works:

Colimesta 4.5 MIU Injection is a bactericidal antibiotic that works by disrupting bacterial cell membranes.

SAFETY ADVICE

AlcoholAlcoholSAFE

Colimesta 4.5 MIU Injection may be used concurrently with alcohol without adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Colimesta 4.5 MIU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Colimesta 4.5 MIU Injection without significant risk to their infants. Available human data indicates minimal infant danger from this medication.

DrivingDrivingUNSAFE

Administering Colimesta 4.5 MIU Injection might induce drowsiness, blurred vision, or dizziness. Driving is discouraged if these effects manifest.

KidneyKidneyCAUTION

Caution is advised when administering Colimesta 4.5 MIU Injection to individuals with impaired renal function. Dosage modifications for Colimesta 4.5 MIU Injection may be necessary. Physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Colimesta 4.5 MIU Injection to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Colimesta 4.5 MIU Injection :

NA

Facts to Know About Colimesta 4.5 MIU Injection

LabelValue
Type of Compound Short chains of amino acids.
Potential for Dependence None.
Medication Classification Agents against infection

FAQs on Colimesta 4.5 MIU Injection

Prior to administering Colimesta 4.5 MIU Injection, inform your physician of any pre-existing or past renal or pulmonary issues, including asthma. Disclose all other medications currently in use, as potential interactions may occur.
Colimesta 4.5 MIU Injection requires administration by a qualified medical practitioner or healthcare provider; self-injection is strictly prohibited. Dosage is determined by your physician based on your specific medical needs. Adhere meticulously to your doctor's prescribed regimen to optimize treatment outcomes with Colimesta 4.5 MIU Injection.
Patients with a known allergy to Colimesta 4.5 MIU Injection or its constituents should not receive this medication. First-time users or those uncertain about potential allergic reactions should seek medical advice before administration.
Insufficient data exists to definitively establish the safety of Colimesta 4.5 MIU Injection during pregnancy. Therefore, pregnant individuals or those planning pregnancy should seek medical advice prior to administration. Use is only advisable under direct physician supervision.
Administering Colimesta 4.5 MIU Injection is safe when adhering to the prescribed dosage and treatment schedule. Strictly follow the recommended usage; do not omit any injections. Closely observe your physician's guidance and report any adverse reactions.
Prior to administering Colimesta 4.5 MIU Injection, inform your physician of any pre-existing or past renal or pulmonary issues, including asthma. Disclose all concurrent medications, as interactions are possible.
Colimesta 4.5 MIU Injection requires administration by a qualified healthcare provider or physician; self-injection is strictly prohibited. Dosage is determined by your physician based on your specific medical needs. Adhere closely to your doctor's prescribed regimen to optimize the therapeutic effects of Colimesta 4.5 MIU Injection.
Colimesta 4.5 MIU Injection is contraindicated in individuals with known hypersensitivity to the injection or its constituents. First-time users or those uncertain about potential allergic reactions should seek medical advice before administration.
Insufficient data exists to definitively determine the safety of Colimesta 4.5 MIU Injection during pregnancy. Pregnant individuals or those planning pregnancy should seek medical advice before using this injection. Its administration should be solely as directed by a physician.
Administering Colimesta 4.5 MIU Injection is safe when used according to your physician's prescribed dosage and schedule. Strictly adhere to the recommended regimen and avoid missed injections. Closely follow your doctor's guidance, reporting any adverse reactions experienced.
Colimesta 4.5 MIU Injecti...
3,836
MRP 4,674
17% off